Consumer Product Safety Commission to review its test protocols. In a letter to Harold D. Stratton, HCPC is requesting a review of the child-resistant tests because of what it sees as an inequity.
The letter to the new chairman notes that there is an objective standard for cap-and-vial tests, but a more subjective criteria used to evaluate unit-dose blister and strip packaging. This results in what HCPC calls a “problematic” decision by pharmaceutical manufacturers’ legal counsel.
